Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Condition(s):Colon Adenocarcinoma; Colorectal CancerLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Colon Adenocarcinoma; Colorectal CancerLast Updated:March 5, 2024Recruiting
Condition(s):Colonic AdenocarcinomaLast Updated:August 18, 2023Recruiting
Condition(s):Colon AdenocarcinomaLast Updated:August 26, 2021Unknown status
Condition(s):Lung Adenocarcinoma; Colon AdenocarcinomaLast Updated:February 10, 2021Completed
Condition(s):Colon CancerLast Updated:December 2, 2014Completed
Condition(s):Rectal Adenocarcinoma; Colon AdenocarcinomaLast Updated:April 16, 2020Completed
Condition(s):Colorectal CancerLast Updated:May 16, 2018Terminated
Condition(s):Adenocarcinoma ColonLast Updated:October 2, 2019Unknown status
Condition(s):Metastatic Adenocarcinoma of the Colon or Rectum; Malignant Solid TumorsLast Updated:May 5, 2021Completed
Condition(s):Colorectal CancerLast Updated:January 24, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.